ARTICLE | Company News
Takeda, TWi Pharmaceuticals deal
June 8, 2015 7:00 AM UTC
TWi and Takeda settled all patent litigation related to TWi’s generic of Takeda’s Dexilant dexlansoprazole for gastroesophageal reflux disease (GERD). Under the agreement, TWi will be allowed to laun...